4.5 Review

Novel N-methyl-D-aspartate receptor antagonists: a review of compounds patented since 2006

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Chemistry, Medicinal

Stability Studies of Oxazolidine-Based Compounds Using 1H NMR Spectroscopy

Gerard P. Moloney et al.

JOURNAL OF PHARMACEUTICAL SCIENCES (2010)

Review Chemistry, Medicinal

PET and SPECT Imaging of the NMDA Receptor System: An Overview of Radiotracer Development

F. Sobrio et al.

MINI-REVIEWS IN MEDICINAL CHEMISTRY (2010)

Review Neurosciences

Influence of the NR3A subunit on NMDA receptor functions

Maile A. Henson et al.

PROGRESS IN NEUROBIOLOGY (2010)

Article Pharmacology & Pharmacy

Efficacy of 3,5-dibromo-L-phenylalanine in rat models of stroke, seizures and sensorimotor gating deficit

W. Cao et al.

BRITISH JOURNAL OF PHARMACOLOGY (2009)

Review Pharmacology & Pharmacy

Allosteric modulators of NR2B-containing NMDA receptors: molecular mechanisms and therapeutic potential

Laetitia Mony et al.

BRITISH JOURNAL OF PHARMACOLOGY (2009)

Article Chemistry, Medicinal

Molecular determinants of the anticonvulsant felbamate binding site in the N-methyl-D-aspartate receptor

Huai-Ren Chang et al.

JOURNAL OF MEDICINAL CHEMISTRY (2008)

Article Chemistry, Medicinal

Enantiomeric propanolamines as selective N-methyl-D-aspartate 2B receptor antagonists

Yesim A. Tahirovic et al.

JOURNAL OF MEDICINAL CHEMISTRY (2008)

Review Clinical Neurology

Potentiation of the NMDA receptor in the treatment of schizophrenia: focused on the glycine site

Seong S. Shim et al.

EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2007)

Review Pharmacology & Pharmacy

NMDA receptor subunits: function and pharmacology

Pierre Paoletti et al.

CURRENT OPINION IN PHARMACOLOGY (2007)

Review Neurosciences

Hippocampal long-term depression: master or minion in declarative memory processes?

Anne Kemp et al.

TRENDS IN NEUROSCIENCES (2007)

Review Pharmacology & Pharmacy

Behavioural pharmacology: 40+years of progress, with a focus on glutamate receptors and cognition

TW Robbins et al.

TRENDS IN PHARMACOLOGICAL SCIENCES (2006)

Review Chemistry, Medicinal

Progress towards validating the NMDA receptor hypofunction hypothesis of schizophrenia

Craig W. Lindsley et al.

CURRENT TOPICS IN MEDICINAL CHEMISTRY (2006)

Review Chemistry, Medicinal

NR2B selective NMDA antagonists: The evolution of the ifenprodil-type pharmaeophore

Istvan Borza et al.

CURRENT TOPICS IN MEDICINAL CHEMISTRY (2006)

Article Chemistry, Medicinal

Indole-2-carboxamidines as novel NR2B selective NMDA receptor antagonists

I Borza et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)

Article Pharmacology & Pharmacy

Differential modulation of glutamatergic transmission by 3,5-dibromo-L-phenylalanine

V Yarotskyy et al.

MOLECULAR PHARMACOLOGY (2005)

Article Chemistry, Medicinal

Orally efficacious NR2B-selective NMDA receptor antagonists

CF Claiborne et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2003)

Article Medicine, Research & Experimental

Comparative study of action mechanisms of dimebon and memantine on AMPA- and NMDA-subtypes glutamate receptors in rat cerebral neurons

VV Grigor'ev et al.

BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE (2003)

Article Pharmacology & Pharmacy

EAA-090 - Neuroprotectant, Competitive NMDA antagonist

WE Childers et al.

DRUGS OF THE FUTURE (2002)